UPDATE - Tevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly Financials
Since its founding in 2020, Tevogen Bio has developed a significant asset portfolio, and kept expenditures under $40 million, a ...
Tevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly Financials
Since its founding in 2020, Tevogen Bio has developed a significant asset portfolio, and kept expenditures under $40 million, a ...
Tevogen Bio Shares Are On The Rise Monday: What's Going On?
Tevogen Bio Holdings Inc. (NASDAQ: TVGN) shares are trading higher Monday, potentially driven by momentum from a late-Friday ...
Tevogen Bio Partners with Microsoft Corporation (MSFT) to Leverage Advanced AI Tools for Biotech Research in Healthcare
We recently compiled a list of the 10 AI News and Ratings Investors Should Not Miss. In this article, we are going to take a ...
GlobalData on MSN8d
Tevogen Bio partners Microsoft for HPV treatment
By leveraging Microsoft's advanced tool collection, Tevogen Bio aims to establish an oncology product portfolio.
manilatimes10d
Tevogen Bio Announces Appointment of Anthony Tarantino as Patient Advocate to Enhance Community Engagement and Patient Support
WARREN, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio ("Tevogen” or "Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a ...
manilatimes16d
Tevogen Bio Signs Letter of Intent With CD8 Technology to Build Up to a $50 Million R&D and Manufacturing Facility; No Impact on Shareholder Equity
CD8 Technology Services, LLC ("CD8 Technology”) to provide turn-key facility for Tevogen Bio Reinforces Tevogen Bio's ...
Investing9d
Tevogen Bio advances HPV oncology treatment TVGN 920
WARREN, N.J. - Tevogen Bio, a clinical-stage immunotherapy company, announced the initiation of its pre-clinical efforts for TVGN 920, a potential treatment targeting Human Papillomavirus (HPV).
Insider Monkey3d
Tevogen Bio Partners with Microsoft Corporation (MSFT) to Leverage Advanced AI Tools for Biotech Research in Healthcare
Microsoft Corporation (NASDAQ:MSFT) is a Washington-based technology company. On November 5, Tevogen Bio, a New Jersey-based biotech firm, announced that Tevogen AI, the AI department of the ...
Mena FN10d
Tevogen Bio Announces Appointment Of Anthony Tarantino As Patient Advocate To Enhance Community Engagement And Patient Support
(MENAFN- GlobeNewsWire - Nasdaq) WARREN, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or“Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ), a ...